A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide-Reference-Cited by-同舟云学术

A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide

Published:2013-10-11 Issue:10 Volume:191 Page:4969-4978
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Luo Qiong,Sun Yang,Liu Wen,Qian Cheng,Jin Biao,Tao Feifei,Gu Yanhong,Wu Xingxin,Shen Yan,Xu Qiang

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Cytokines in the pathogenesis of rheumatoid arthritis

2. Therapeutic strategies for rheumatoid arthritis

3. The Pathogenesis of Rheumatoid Arthritis

4. Genetic aspects of rheumatoid arthritis.;Lanchbury;Clin. Exp. Rheumatol.,1993

5. Genetic aspects of rheumatoid arthritis

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional herbal medicine: Therapeutic potential in acute gouty arthritis;Journal of Ethnopharmacology;2024-08

2. The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis;Chinese Medical Journal;2024-07-26

3. Iguratimod Alleviates Experimental Sjögren’s Syndrome by Inhibiting NLRP3 Inflammasome Activation;Cell Biochemistry and Biophysics;2024-06-05

4. Efficacy and safety of iguratimod combined with celecoxib in active axial spondyloarthritis: a randomized, double-blind, placebo-controlled study;Scandinavian Journal of Rheumatology;2024-06-04

5. Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren’s syndrome in mice by promoting TEC kinase degradation;Acta Pharmacologica Sinica;2024-05-14